Global Quadrivalent Meningococcal Vaccine Market Growth 2026-2032
The global Quadrivalent Meningococcal Vaccine market size is predicted to grow from US$ 189 million in 2025 to US$ 283 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.
Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.
LP Information, Inc. (LPI) ' newest research report, the “Quadrivalent Meningococcal Vaccine Industry Forecast” looks at past sales and reviews total world Quadrivalent Meningococcal Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Quadrivalent Meningococcal Vaccine sales for 2026 through 2032. With Quadrivalent Meningococcal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quadrivalent Meningococcal Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Quadrivalent Meningococcal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quadrivalent Meningococcal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quadrivalent Meningococcal Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quadrivalent Meningococcal Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quadrivalent Meningococcal Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Quadrivalent Meningococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.
Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.
LP Information, Inc. (LPI) ' newest research report, the “Quadrivalent Meningococcal Vaccine Industry Forecast” looks at past sales and reviews total world Quadrivalent Meningococcal Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Quadrivalent Meningococcal Vaccine sales for 2026 through 2032. With Quadrivalent Meningococcal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quadrivalent Meningococcal Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Quadrivalent Meningococcal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quadrivalent Meningococcal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quadrivalent Meningococcal Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quadrivalent Meningococcal Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quadrivalent Meningococcal Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Quadrivalent Meningococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Polysaccharide Vaccine
- Conjugate Vaccine
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi-Pasteur
- Walvax
- Chengdu Kanghua Biological Products Co., Ltd.
- Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
- Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
- Beijing Institute of Biological Products Co., Ltd.
- CanSino Biological Co., Ltd.
- Hualan Biological Vaccine Co., Ltd.
- Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
- What is the 10-year outlook for the global Quadrivalent Meningococcal Vaccine market?
- What factors are driving Quadrivalent Meningococcal Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Quadrivalent Meningococcal Vaccine market opportunities vary by end market size?
- How does Quadrivalent Meningococcal Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quadrivalent Meningococcal Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Quadrivalent Meningococcal Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Quadrivalent Meningococcal Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Quadrivalent Meningococcal Vaccine Segment by Type
2.2.1 Polysaccharide Vaccine
2.2.2 Conjugate Vaccine
2.2.3 Quadrivalent Meningococcal Vaccine Sales by Type
2.2.3.1 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Quadrivalent Meningococcal Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Quadrivalent Meningococcal Vaccine Sale Price by Type (2021-2026)
2.3 Quadrivalent Meningococcal Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Quadrivalent Meningococcal Vaccine Sales by Application
2.3.3.1 Global Quadrivalent Meningococcal Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Quadrivalent Meningococcal Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Quadrivalent Meningococcal Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Quadrivalent Meningococcal Vaccine Breakdown Data by Company
3.1.1 Global Quadrivalent Meningococcal Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Quadrivalent Meningococcal Vaccine Revenue by Company (2021-2026)
3.2.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Quadrivalent Meningococcal Vaccine Sale Price by Company
3.4 Key Manufacturers Quadrivalent Meningococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quadrivalent Meningococcal Vaccine Product Location Distribution
3.4.2 Players Quadrivalent Meningococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR QUADRIVALENT MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Quadrivalent Meningococcal Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Quadrivalent Meningococcal Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Quadrivalent Meningococcal Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Quadrivalent Meningococcal Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Quadrivalent Meningococcal Vaccine Sales Growth
4.4 APAC Quadrivalent Meningococcal Vaccine Sales Growth
4.5 Europe Quadrivalent Meningococcal Vaccine Sales Growth
4.6 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Quadrivalent Meningococcal Vaccine Sales by Country
5.1.1 Americas Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026)
5.1.2 Americas Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026)
5.2 Americas Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
5.3 Americas Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quadrivalent Meningococcal Vaccine Sales by Region
6.1.1 APAC Quadrivalent Meningococcal Vaccine Sales by Region (2021-2026)
6.1.2 APAC Quadrivalent Meningococcal Vaccine Revenue by Region (2021-2026)
6.2 APAC Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
6.3 APAC Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Quadrivalent Meningococcal Vaccine by Country
7.1.1 Europe Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026)
7.1.2 Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026)
7.2 Europe Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
7.3 Europe Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quadrivalent Meningococcal Vaccine by Country
8.1.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quadrivalent Meningococcal Vaccine
10.3 Manufacturing Process Analysis of Quadrivalent Meningococcal Vaccine
10.4 Industry Chain Structure of Quadrivalent Meningococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quadrivalent Meningococcal Vaccine Distributors
11.3 Quadrivalent Meningococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR QUADRIVALENT MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Region
12.1.1 Global Quadrivalent Meningococcal Vaccine Forecast by Region (2027-2032)
12.1.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Quadrivalent Meningococcal Vaccine Forecast by Type (2027-2032)
12.7 Global Quadrivalent Meningococcal Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi-Pasteur
13.1.1 Sanofi-Pasteur Company Information
13.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi-Pasteur Main Business Overview
13.1.5 Sanofi-Pasteur Latest Developments
13.2 Walvax
13.2.1 Walvax Company Information
13.2.2 Walvax Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.2.3 Walvax Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Walvax Main Business Overview
13.2.5 Walvax Latest Developments
13.3 Chengdu Kanghua Biological Products Co., Ltd.
13.3.1 Chengdu Kanghua Biological Products Co., Ltd. Company Information
13.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chengdu Kanghua Biological Products Co., Ltd. Main Business Overview
13.3.5 Chengdu Kanghua Biological Products Co., Ltd. Latest Developments
13.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
13.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information
13.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Main Business Overview
13.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Latest Developments
13.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
13.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information
13.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Main Business Overview
13.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Latest Developments
13.6 Beijing Institute of Biological Products Co., Ltd.
13.6.1 Beijing Institute of Biological Products Co., Ltd. Company Information
13.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Beijing Institute of Biological Products Co., Ltd. Main Business Overview
13.6.5 Beijing Institute of Biological Products Co., Ltd. Latest Developments
13.7 CanSino Biological Co., Ltd.
13.7.1 CanSino Biological Co., Ltd. Company Information
13.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CanSino Biological Co., Ltd. Main Business Overview
13.7.5 CanSino Biological Co., Ltd. Latest Developments
13.8 Hualan Biological Vaccine Co., Ltd.
13.8.1 Hualan Biological Vaccine Co., Ltd. Company Information
13.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hualan Biological Vaccine Co., Ltd. Main Business Overview
13.8.5 Hualan Biological Vaccine Co., Ltd. Latest Developments
13.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
13.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information
13.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Main Business Overview
13.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quadrivalent Meningococcal Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Quadrivalent Meningococcal Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Quadrivalent Meningococcal Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Quadrivalent Meningococcal Vaccine Segment by Type
2.2.1 Polysaccharide Vaccine
2.2.2 Conjugate Vaccine
2.2.3 Quadrivalent Meningococcal Vaccine Sales by Type
2.2.3.1 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Quadrivalent Meningococcal Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Quadrivalent Meningococcal Vaccine Sale Price by Type (2021-2026)
2.3 Quadrivalent Meningococcal Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Quadrivalent Meningococcal Vaccine Sales by Application
2.3.3.1 Global Quadrivalent Meningococcal Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Quadrivalent Meningococcal Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Quadrivalent Meningococcal Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Quadrivalent Meningococcal Vaccine Breakdown Data by Company
3.1.1 Global Quadrivalent Meningococcal Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Quadrivalent Meningococcal Vaccine Revenue by Company (2021-2026)
3.2.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Quadrivalent Meningococcal Vaccine Sale Price by Company
3.4 Key Manufacturers Quadrivalent Meningococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quadrivalent Meningococcal Vaccine Product Location Distribution
3.4.2 Players Quadrivalent Meningococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR QUADRIVALENT MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Quadrivalent Meningococcal Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Quadrivalent Meningococcal Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Quadrivalent Meningococcal Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Quadrivalent Meningococcal Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Quadrivalent Meningococcal Vaccine Sales Growth
4.4 APAC Quadrivalent Meningococcal Vaccine Sales Growth
4.5 Europe Quadrivalent Meningococcal Vaccine Sales Growth
4.6 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Quadrivalent Meningococcal Vaccine Sales by Country
5.1.1 Americas Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026)
5.1.2 Americas Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026)
5.2 Americas Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
5.3 Americas Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quadrivalent Meningococcal Vaccine Sales by Region
6.1.1 APAC Quadrivalent Meningococcal Vaccine Sales by Region (2021-2026)
6.1.2 APAC Quadrivalent Meningococcal Vaccine Revenue by Region (2021-2026)
6.2 APAC Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
6.3 APAC Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Quadrivalent Meningococcal Vaccine by Country
7.1.1 Europe Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026)
7.1.2 Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026)
7.2 Europe Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
7.3 Europe Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quadrivalent Meningococcal Vaccine by Country
8.1.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quadrivalent Meningococcal Vaccine
10.3 Manufacturing Process Analysis of Quadrivalent Meningococcal Vaccine
10.4 Industry Chain Structure of Quadrivalent Meningococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quadrivalent Meningococcal Vaccine Distributors
11.3 Quadrivalent Meningococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR QUADRIVALENT MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Region
12.1.1 Global Quadrivalent Meningococcal Vaccine Forecast by Region (2027-2032)
12.1.2 Global Quadrivalent Meningococcal Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Quadrivalent Meningococcal Vaccine Forecast by Type (2027-2032)
12.7 Global Quadrivalent Meningococcal Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi-Pasteur
13.1.1 Sanofi-Pasteur Company Information
13.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi-Pasteur Main Business Overview
13.1.5 Sanofi-Pasteur Latest Developments
13.2 Walvax
13.2.1 Walvax Company Information
13.2.2 Walvax Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.2.3 Walvax Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Walvax Main Business Overview
13.2.5 Walvax Latest Developments
13.3 Chengdu Kanghua Biological Products Co., Ltd.
13.3.1 Chengdu Kanghua Biological Products Co., Ltd. Company Information
13.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chengdu Kanghua Biological Products Co., Ltd. Main Business Overview
13.3.5 Chengdu Kanghua Biological Products Co., Ltd. Latest Developments
13.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
13.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information
13.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Main Business Overview
13.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Latest Developments
13.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
13.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information
13.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Main Business Overview
13.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Latest Developments
13.6 Beijing Institute of Biological Products Co., Ltd.
13.6.1 Beijing Institute of Biological Products Co., Ltd. Company Information
13.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Beijing Institute of Biological Products Co., Ltd. Main Business Overview
13.6.5 Beijing Institute of Biological Products Co., Ltd. Latest Developments
13.7 CanSino Biological Co., Ltd.
13.7.1 CanSino Biological Co., Ltd. Company Information
13.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CanSino Biological Co., Ltd. Main Business Overview
13.7.5 CanSino Biological Co., Ltd. Latest Developments
13.8 Hualan Biological Vaccine Co., Ltd.
13.8.1 Hualan Biological Vaccine Co., Ltd. Company Information
13.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hualan Biological Vaccine Co., Ltd. Main Business Overview
13.8.5 Hualan Biological Vaccine Co., Ltd. Latest Developments
13.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
13.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information
13.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
13.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Main Business Overview
13.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Quadrivalent Meningococcal Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Quadrivalent Meningococcal Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polysaccharide Vaccine
Table 4. Major Players of Conjugate Vaccine
Table 5. Global Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Quadrivalent Meningococcal Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Quadrivalent Meningococcal Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Quadrivalent Meningococcal Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Quadrivalent Meningococcal Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Quadrivalent Meningococcal Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Quadrivalent Meningococcal Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Quadrivalent Meningococcal Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Quadrivalent Meningococcal Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Quadrivalent Meningococcal Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Quadrivalent Meningococcal Vaccine Producing Area Distribution and Sales Area
Table 21. Players Quadrivalent Meningococcal Vaccine Products Offered
Table 22. Quadrivalent Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Quadrivalent Meningococcal Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Quadrivalent Meningococcal Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Quadrivalent Meningococcal Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Quadrivalent Meningococcal Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Quadrivalent Meningococcal Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Quadrivalent Meningococcal Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Quadrivalent Meningococcal Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Quadrivalent Meningococcal Vaccine
Table 52. Key Market Challenges & Risks of Quadrivalent Meningococcal Vaccine
Table 53. Key Industry Trends of Quadrivalent Meningococcal Vaccine
Table 54. Quadrivalent Meningococcal Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Quadrivalent Meningococcal Vaccine Distributors List
Table 57. Quadrivalent Meningococcal Vaccine Customer List
Table 58. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Quadrivalent Meningococcal Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Quadrivalent Meningococcal Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Quadrivalent Meningococcal Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Quadrivalent Meningococcal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Quadrivalent Meningococcal Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Quadrivalent Meningococcal Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi-Pasteur Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 74. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi-Pasteur Main Business
Table 76. Sanofi-Pasteur Latest Developments
Table 77. Walvax Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Walvax Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 79. Walvax Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Walvax Main Business
Table 81. Walvax Latest Developments
Table 82. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 84. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chengdu Kanghua Biological Products Co., Ltd. Main Business
Table 86. Chengdu Kanghua Biological Products Co., Ltd. Latest Developments
Table 87. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 89. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Main Business
Table 91. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Latest Developments
Table 92. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 94. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Main Business
Table 96. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Latest Developments
Table 97. Beijing Institute of Biological Products Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 99. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Beijing Institute of Biological Products Co., Ltd. Main Business
Table 101. Beijing Institute of Biological Products Co., Ltd. Latest Developments
Table 102. CanSino Biological Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 104. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CanSino Biological Co., Ltd. Main Business
Table 106. CanSino Biological Co., Ltd. Latest Developments
Table 107. Hualan Biological Vaccine Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 109. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Hualan Biological Vaccine Co., Ltd. Main Business
Table 111. Hualan Biological Vaccine Co., Ltd. Latest Developments
Table 112. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 114. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Main Business
Table 116. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Latest Developments
Table 1. Quadrivalent Meningococcal Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Quadrivalent Meningococcal Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polysaccharide Vaccine
Table 4. Major Players of Conjugate Vaccine
Table 5. Global Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Quadrivalent Meningococcal Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Quadrivalent Meningococcal Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Quadrivalent Meningococcal Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Quadrivalent Meningococcal Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Quadrivalent Meningococcal Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Quadrivalent Meningococcal Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Quadrivalent Meningococcal Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Quadrivalent Meningococcal Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Quadrivalent Meningococcal Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Quadrivalent Meningococcal Vaccine Producing Area Distribution and Sales Area
Table 21. Players Quadrivalent Meningococcal Vaccine Products Offered
Table 22. Quadrivalent Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Quadrivalent Meningococcal Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Quadrivalent Meningococcal Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Quadrivalent Meningococcal Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Quadrivalent Meningococcal Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Quadrivalent Meningococcal Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Quadrivalent Meningococcal Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Quadrivalent Meningococcal Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Quadrivalent Meningococcal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Quadrivalent Meningococcal Vaccine
Table 52. Key Market Challenges & Risks of Quadrivalent Meningococcal Vaccine
Table 53. Key Industry Trends of Quadrivalent Meningococcal Vaccine
Table 54. Quadrivalent Meningococcal Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Quadrivalent Meningococcal Vaccine Distributors List
Table 57. Quadrivalent Meningococcal Vaccine Customer List
Table 58. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Quadrivalent Meningococcal Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Quadrivalent Meningococcal Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Quadrivalent Meningococcal Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Quadrivalent Meningococcal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Quadrivalent Meningococcal Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Quadrivalent Meningococcal Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi-Pasteur Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 74. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi-Pasteur Main Business
Table 76. Sanofi-Pasteur Latest Developments
Table 77. Walvax Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Walvax Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 79. Walvax Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Walvax Main Business
Table 81. Walvax Latest Developments
Table 82. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 84. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chengdu Kanghua Biological Products Co., Ltd. Main Business
Table 86. Chengdu Kanghua Biological Products Co., Ltd. Latest Developments
Table 87. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 89. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Main Business
Table 91. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Latest Developments
Table 92. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 94. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Main Business
Table 96. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Latest Developments
Table 97. Beijing Institute of Biological Products Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 99. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Beijing Institute of Biological Products Co., Ltd. Main Business
Table 101. Beijing Institute of Biological Products Co., Ltd. Latest Developments
Table 102. CanSino Biological Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 104. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CanSino Biological Co., Ltd. Main Business
Table 106. CanSino Biological Co., Ltd. Latest Developments
Table 107. Hualan Biological Vaccine Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 109. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Hualan Biological Vaccine Co., Ltd. Main Business
Table 111. Hualan Biological Vaccine Co., Ltd. Latest Developments
Table 112. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Quadrivalent Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Portfolios and Specifications
Table 114. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Main Business
Table 116. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Quadrivalent Meningococcal Vaccine
Figure 2. Quadrivalent Meningococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Quadrivalent Meningococcal Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Quadrivalent Meningococcal Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Quadrivalent Meningococcal Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Quadrivalent Meningococcal Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Polysaccharide Vaccine
Figure 12. Product Picture of Conjugate Vaccine
Figure 13. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type in 2026
Figure 14. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Quadrivalent Meningococcal Vaccine Consumed in Hospital
Figure 16. Global Quadrivalent Meningococcal Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Quadrivalent Meningococcal Vaccine Consumed in Clinic
Figure 18. Global Quadrivalent Meningococcal Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Quadrivalent Meningococcal Vaccine Sale Market Share by Application (2025)
Figure 20. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application in 2026
Figure 21. Quadrivalent Meningococcal Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Company in 2026
Figure 23. Quadrivalent Meningococcal Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Quadrivalent Meningococcal Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Quadrivalent Meningococcal Vaccine
Figure 73. Industry Chain Structure of Quadrivalent Meningococcal Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Quadrivalent Meningococcal Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Quadrivalent Meningococcal Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Quadrivalent Meningococcal Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Quadrivalent Meningococcal Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Quadrivalent Meningococcal Vaccine
Figure 2. Quadrivalent Meningococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Quadrivalent Meningococcal Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Quadrivalent Meningococcal Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Quadrivalent Meningococcal Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Quadrivalent Meningococcal Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Polysaccharide Vaccine
Figure 12. Product Picture of Conjugate Vaccine
Figure 13. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type in 2026
Figure 14. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Quadrivalent Meningococcal Vaccine Consumed in Hospital
Figure 16. Global Quadrivalent Meningococcal Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Quadrivalent Meningococcal Vaccine Consumed in Clinic
Figure 18. Global Quadrivalent Meningococcal Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Quadrivalent Meningococcal Vaccine Sale Market Share by Application (2025)
Figure 20. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Application in 2026
Figure 21. Quadrivalent Meningococcal Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Company in 2026
Figure 23. Quadrivalent Meningococcal Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Quadrivalent Meningococcal Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Quadrivalent Meningococcal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Quadrivalent Meningococcal Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Quadrivalent Meningococcal Vaccine
Figure 73. Industry Chain Structure of Quadrivalent Meningococcal Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Quadrivalent Meningococcal Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Quadrivalent Meningococcal Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Quadrivalent Meningococcal Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Quadrivalent Meningococcal Vaccine Revenue Market Share Forecast by Application (2027-2032)
